NDC properties for NDC 9 0054-4581
NDC item 00054458111
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-11 |
| NDC Item | 00054458111 |
| packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0054-4581-11) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
NDC item 00054458127
| NDC 9 | 0054-4581 |
|---|---|
| NDC 10 | 0054-4581-27 |
| NDC Item | 00054458127 |
| packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0054-4581-27) |
| ANDA | ANDA040528 |
| COLORTEXT | YELLOW(pale) |
| Color | C48330 __ |
| FDA SPL set id | 802002 |
| Imprint code | 54;420 |
| Labeler | Hikma Pharmaceuticals USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2004-02-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shapetext | biconvex |
| Shape | C48348 |
| Size | 10 mm |
NDC item 00378354725
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-25 |
| NDC Item | 00378354725 |
| packaging | 250 TABLET in 1 BOTTLE, PLASTIC (0378-3547-25) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
NDC item 00378354752
| NDC 9 | 0378-3547 |
|---|---|
| NDC 10 | 0378-3547-52 |
| NDC Item | 00378354752 |
| packaging | 25 TABLET in 1 BOTTLE, PLASTIC (0378-3547-52) |
| ANDA | ANDA040594 |
| COLORTEXT | WHITE(off-white to light yellow) |
| Color | C48325 __ |
| FDA SPL set id | 752465 |
| Imprint code | M;547 |
| Labeler | Mylan Pharmaceuticals Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-07-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 10 mm |
NDC item 69076091302
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-02 |
| NDC Item | 69076091302 |
| packaging | 25 TABLET in 1 BOTTLE, PLASTIC (69076-913-02) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |
NDC item 69076091325
| NDC 9 | 69076-913 |
|---|---|
| NDC 10 | 69076-913-25 |
| NDC Item | 69076091325 |
| packaging | 250 TABLET in 1 BOTTLE, PLASTIC (69076-913-25) |
| COLORTEXT | yellow(Pale yellow to buff) |
| Color | C48330 __ |
| FDA SPL set id | 799400 |
| Imprint code | 9;3 |
| Labeler | Quinn Pharmaceuticals |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time high | 2024-10-31 |
| Marketing effective time low | 2016-10-05 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA009053 |
| Score | 2 |
| Shape | C48348 |
| Size | 9 mm |